LSB

LakeShore Biopharma
LSB

Delisted

LSB was delisted on the 19th of September, 2025.

Back to rankings

1 hedge funds and large institutions have $18.1K invested in LakeShore Biopharma in 2025 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 6 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
1
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$119K
2
-$76.7K
3
-$55.9K
4
SCM
Superstring Capital Management
New York
-$31.4K
5
Citadel Advisors
Citadel Advisors
Florida
-$15.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
1
Barclays
United Kingdom
$18.1K
Fidelity Investments
2
Fidelity Investments
Massachusetts
–
HA
3
HHLR Advisors
Cayman Islands
–
O
4
OrbiMed
New York
–
SCM
5
Superstring Capital Management
New York
–
Citadel Advisors
6
Citadel Advisors
Florida
–
UBS Group
7
UBS Group
Switzerland
–